OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacological Reviews is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-04-01 to 2026-04-01.)

Article	Citations
Seventy-Five Years of Interactions: The Department of Physiology and Pharmacology at Karolinska Institutet and Pharmacological Reviews	404
The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes	397
Innovative therapeutics for renoprotection: Where we are	245
Review of Natural Language Processing in Pharmacology	182
The Nitrogen Mustards	166
The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics	149
Reimagining pharmacology education	144
Table of Contents	139
Table of Contents	132
Carbonic anhydrase inhibitors: “Old” drugs with new potential in unexpected areas	116
Therapeutic advantage of combinatorial chimeric antigen receptor T cell and chemotherapies	113
The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets	111
Metal-based antibody, nanobody, and peptide conjugates: Potential for breast cancer therapy	105
Table of Contents	103
Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems	101
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023	99
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins	96
Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes	92
Optical Approaches for Investigating Neuromodulation and G Protein–Coupled Receptor Signaling	87
Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases	77
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer	73
Table of Contents	70
The Hippo pathway: Organ size control and beyond	67
G Protein-Coupled Receptor Pharmacology—Insights from Mass Spectrometry	66
Asthma therapeutics: Past, present, and future	65

miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response	63
Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response	62
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases	59
Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism	57
Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications	57
Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy	52
Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood	51
Corrigendum to “International Union of Basic and Clinical Pharmacology. CXIX. Fundamental insights and clinical relevance regarding the carnitine palmitoyltransferase family of enzymes” [Pharmacologic	51
Nonhormonal Male Contraceptive Development—Strategies for Progress	50
Sulfotransferase 2B1b, Sterol Sulfonation, and Disease	49
From neuroimmune circuits to targeted therapy of chronic pruritus	48
Neurobiology of the incubation of drug craving: An update	48
Dopamine, Immunity, and Disease	47
Pharmacological Reviews’ 75th Year Anniversary: Past and Future—Editorial	45
Editorial Board	45
Extracellular Vesicle Heterogeneity and Its Impact for Regenerative Medicine Applications	45
Animal Behavior in Psychedelic Research	44
Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks	42
Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions	42
Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting	42